COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers (INTERGLIKOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04198948
Recruitment Status : Completed
First Posted : December 13, 2019
Last Update Posted : February 5, 2020
General Hospital Prim. Dr. Abdulah Nakas
University of Dundee
Information provided by (Responsible Party):
Tanja Dujic, PhD, University of Sarajevo

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 5, 2019
Actual Study Completion Date : August 5, 2019